Company profile for SMSbiotech

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

SMSbiotech is a pre-clinical, late-stage biotech company pioneering the use of Small Mobile Stem cells. Our proprietary, patented technology revolutionizes how the life science industry researches cells, drugs, and toxins. By enabling earlier and more cost-effective testing, our platform advances regenerative medicine and bio-manufacturing. With a team of expert scientists and business leaders, we drive the development of inno...
SMSbiotech is a pre-clinical, late-stage biotech company pioneering the use of Small Mobile Stem cells. Our proprietary, patented technology revolutionizes how the life science industry researches cells, drugs, and toxins. By enabling earlier and more cost-effective testing, our platform advances regenerative medicine and bio-manufacturing. With a team of expert scientists and business leaders, we drive the development of innovative therapies, transforming scientific discoveries into life-changing treatments for chronic and degenerative diseases.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1825 Diamond St # 101, San Marcos, CA 92078
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20250821443319/en/SMSbiotech-Initiates-Groundbreaking-Phase-1-Human-Clinical-Trial-for-COPD

BUSINESSWIRE
21 Aug 2025

https://www.businesswire.com/news/home/20250422997382/en/SMSbiotech-Establishes-a-Cooperative-Research-and-Development-Agreement-with-the-U.S.-Army-Medical-Research-Institute-of-Chemical-Defense

BUSINESSWIRE
22 Apr 2025

https://www.businesswire.com/news/home/20250318995283/en/SMSbiotech-Receives-Green-Light-for-Phase-I-Clinical-Trial-in-Australia-Targeting-COPD

BUSINESSWIRE
18 Mar 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty